Exhibit_23_CAHPS_Survery_MAPD.xlsx

This document is an Excel exhibit (Exhibit 23) related to a CAHPS (Consumer Assessment of Healthcare Providers and Systems) Survey for a potential MAPD (Medicare Advantage Prescription Drug) program, with a specific focus on an OEIBA Program. The exhibit requires suppliers to attach a copy of their CAHPS survey results for the 2024 reporting period, as specified in Attachment E, section D.13. If a supplier cannot provide CAHPS results, they are permitted to submit annual HEDIS (Healthcare Effectiveness Data and Information Set) results as an acceptable alternative.

The exhibit appears to be part of a healthcare program evaluation process, where survey results are used to assess the quality and performance of healthcare providers or plans. The document outlines a documentation submission requirement, giving suppliers flexibility in meeting the reporting standard by allowing HEDIS results as a backup option. While specific details about the full contract, funding sources, or precise evaluation criteria are not included in this exhibit, it suggests a comprehensive quality assessment mechanism for healthcare service providers participating in the program.